XML 21 R11.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SEGMENT REPORTING
3 Months Ended
Jul. 31, 2024
Segment Reporting [Abstract]  
SEGMENT REPORTING

NOTE 3 SEGMENT REPORTING

 

Currently, the Company has two reportable business segments:

 

(i) Consulting Service Segment, mainly provides consulting advisory services in management business, accounting and financial services; and
(ii) Healthcare Segment, mainly provides healthcare products to customers, most of them are distributors.

 

In the following table, revenue is disaggregated by primary major product line, including a reconciliation of the disaggregated revenue with the reportable segments. For the three months ended July 31, 2023, the consulting service and healthcare segment did not generate any revenue.

               
   Three Months ended July 31, 2024
   Healthcare
Segment
  Consulting Service
Segment
  Total
Revenue from external customers:               
Consulting service income  $   $   $ 
Sale of healthcare products   108,477        108,477 
Total revenue   108,477        108,477 
                
Cost of revenue:               
Consulting service income            
Sale of healthcare products   (35,304)       (35,304)
Total cost of revenue   (35,304)       (35,304)
                
Gross profit   73,173        73,173 
                
Operating Expenses               
Selling and distribution   (7,030)       (7,030)
Personal and benefit costs   (18,739)   (35,245)   (53,984)
General and administrative   (751)   (56,822)   (57,573)
Total operating expenses   (26,520)   (92,067)   (118,587)
                
Segment income (loss)  $46,653   $(92,067)  $(45,414)

  

The below revenues are based on the countries in which the customer is located. Summarized financial information concerning the geographic segments is shown in the following tables:

      
   Three Months ended July 31,
   2024  2023
       
Hong Kong  $108,477   $